We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$504B
AUM Growth
+$5.92B
Cap. Flow
-$3.19B
Cap. Flow %
-0.63%
Top 10 Hldgs %
16.49%
Holding
2,620
New
96
Increased
950
Reduced
1,023
Closed
72

Top Buys

Rank Stock Value
1
WFC icon
Wells Fargo
WFC
+$1.31B
2
HD icon
Home Depot
HD
+$1.07B
3
BABA icon
Alibaba
BABA
+$1.06B
4
YUM icon
Yum! Brands
YUM
+$887M
5
HON icon
Honeywell
HON
+$860M

Top Sells

Rank Stock Value
1
N
Netsuite Inc
N
+$1.59B
2
NXPI icon
NXP Semiconductors
NXPI
+$1.33B
3
DHR icon
Danaher
DHR
+$1.13B
4
HBI
Hanesbrands
HBI
+$1.06B
5
TMO icon
Thermo Fisher Scientific
TMO
+$845M

Sector Composition

Rank Sector Weight
1 Financials 16.86%
2 Healthcare 16.8%
3 Consumer Discretionary 15.02%
4 Technology 13.29%
5 Industrials 9.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSE
2126
DELISTED
Trinseo
TSE
$408K ﹤0.01%
+6,879
New +$386K
FSP
2127
Franklin Street Properties
FSP
$46.3M
$407K ﹤0.01%
31,404
CLDX icon
2128
Celldex Therapeutics
CLDX
$3.52B
$405K ﹤0.01%
7,623
CNOB icon
2129
Center Bancorp
CNOB
$1.81B
$404K ﹤0.01%
15,561
-22
-0.1% -$477
CLNY
2130
DELISTED
Colony Capital, Inc.
CLNY
$401K ﹤0.01%
19,800
-15,200
-43% -$298K
WIN
2131
DELISTED
Windstream Holdings Inc
WIN
$400K ﹤0.01%
10,912
+3,553
+48% +$138K
FRGI
2132
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
$399K ﹤0.01%
13,370
-78,740
-85% -$2.19M
CCOI icon
2133
Cogent Communications
CCOI
$525M
$398K ﹤0.01%
9,620
RYAM icon
2134
Rayonier Advanced Materials
RYAM
$561M
$398K ﹤0.01%
25,746
MCBC
2135
DELISTED
Macatawa Bank Corp
MCBC
$397K ﹤0.01%
38,173
OME
2136
DELISTED
Omega Protein
OME
$397K ﹤0.01%
15,850
+3,230
+26% +$76.3K
HEES
2137
DELISTED
H&E Equipment Services
HEES
$395K ﹤0.01%
17,000
+6,700
+65% +$123K
KG
2138
Kestrel Group
KG
$66.3M
$395K ﹤0.01%
1,133
-4
-0.4% -$1.23K
SINA
2139
DELISTED
Sina Corp
SINA
$395K ﹤0.01%
6,495
+3,142
+94% +$225K
HQY icon
2140
HealthEquity
HQY
$8.82B
$394K ﹤0.01%
9,719
-16
-0.2% -$618
MDC
2141
DELISTED
M.D.C. Holdings, Inc.
MDC
$394K ﹤0.01%
19,363
-821
-4% -$15.3K
CBK
2142
DELISTED
Christopher & Banks Corporation
CBK
$394K ﹤0.01%
168,522
-7,500
-4% -$12.8K
REIS
2143
DELISTED
Reis, Inc.
REIS
$394K ﹤0.01%
17,720
ACH
2144
Accendra Health
ACH
$93.1M
$391K ﹤0.01%
11,072
-14,900
-57% -$503K
ONTO icon
2145
Onto Innovation
ONTO
$20.6B
$390K ﹤0.01%
15,574
ITCL
2146
DELISTED
Banco Itau Chile American Depositary Shares (each representing one third of one (1/3) Common Share)
ITCL
$390K ﹤0.01%
31,346
+2,881
+10% +$36.6K
MTGE
2147
DELISTED
MTGE Investment Corp. Common Stock
MTGE
$390K ﹤0.01%
24,851
GNL icon
2148
Global Net Lease
GNL
$1.9B
$385K ﹤0.01%
16,390
-21
-0.1% -$481
PETS icon
2149
PetMed Express
PETS
$43M
$384K ﹤0.01%
16,662
INFI
2150
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$383K ﹤0.01%
283,595
-365
-0.1% -$477

Similar funds

T. Rowe Price Associates's Q4 2016 Portfolio in Review

As of Q4 2016, T. Rowe Price Associates held 2,620 positions worth $504B, up 1.2% from $498B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

T. Rowe Price Associates's Q4 2016 filing shows 96 new, 950 increased, 1,023 reduced and 72 closed positions. Its largest new stake was Adient: 10,357,941 shares worth $607M. The largest sale was Netsuite Inc, an estimated $1.59B.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q4 2016 buy was Adient: 10,357,941 shares worth $607M.
  • T. Rowe Price Associates added most to Wells Fargo in Q4 2016, an estimated $1.31B increase.
  • T. Rowe Price Associates's biggest Q4 2016 reduction was NXP Semiconductors, cutting an estimated $1.33B.
  • T. Rowe Price Associates fully exited Netsuite Inc in Q4 2016, selling an estimated $1.59B.
  • T. Rowe Price Associates's ten largest holdings make up 16% of its $504B portfolio in Q4 2016.
  • T. Rowe Price Associates opened 96 new positions and closed 72 in Q4 2016.
  • T. Rowe Price Associates's portfolio value rose 1.2% quarter-over-quarter to $504B.

Based on T. Rowe Price Associates's 13F filing for Q4 2016, filed 14 Feb 2017.